In particular, the CKD incidence in PI-based or INSTI-based regimens was significantly different between the CD4/CD8 ratio recovered and unrecovered groups, while there was no significant difference in NNRTI-based regimen. The gene discussed is CD8A; the disease is chronic kidney disease.